PGNewsroom



We’ve done a complete overhaul of our hereditary cancer test menu

Published on

We are pleased to introduce highlights to our new cancer testing menu:

Reduced pricing 
Improvements in laboratory technologies allow us to pass along savings to the patient.  Most of our cancer tests are now available for $540.

New buccal specimen collection kits available

Published on

PreventionGenetics has new buccal kits available.  

Our new kits are easy to use and require only one swab.

To order our new buccal kits, complete our Online Kit Order Form.

For full specimen requirement infomation, see our specimen requirements page.

 

President's Corner - Exome Tests are Not All the Same

Published on

Many think that exome sequencing tests from different labs are basically the same and that the only important differentiator is price. In reality, exome (and genome) sequencing tests vary greatly among labs.

PGxome®-Based Tests Validated for Copy Number Variants

Published on

We are pleased to announce that all of PreventionGenetics’ PGxome® (whole exome sequencing) based sequencing tests are now validated for copy number variant (CNV) detection.  In many cases, this will alleviate the need for chromosomal microarray (CMA) or gene-centric array Comparative Genomic Hybridization(aCGH) tests, thereby increasing the value for you and your patients!

PreventionGenetics announces integration with FDNA's deep learning platform, Face2Gene to increase the diagnostic power of genetic testing

Published on

November 29, 2017, Marshfield, WI – PreventionGenetics today announces integration of their genetic testing and interpretation services with FDNA’s (www.fdna.com) Face2Gene suite of applications (www.face2gene.com). 

The integration with Face2Gene increases the diagnostic power of PreventionGenetics’ genetic testing using artificial intelligence and computer vision technology, which highlights genetic variants that are highly correlated with disease and the patient’s clinical phenotype.